{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:26:19Z","timestamp":1776702379905,"version":"3.51.2"},"publisher-location":"Chichester, UK","reference-count":56,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd006897.pub2","type":"reference-entry","created":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T16:25:03Z","timestamp":1317227103000},"source":"Crossref","is-referenced-by-count":14,"title":["Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease"],"prefix":"10.1002","author":[{"given":"Julia AE","family":"Walters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Morley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Wood-Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,10,5]]},"reference":[{"issue":"Suppl 49","key":"10.1002\/14651858.CD006897.pub2-BIB1|cit1","first-page":"Abstract No. 19","article-title":"The efficacy and treatment length of oral corticosteroids in patients with acute exacerbations of chronic obstructive pulmonary disease [Abstract]","volume":"26","author":"Chen","year":"2005","journal-title":"European Respiratory Journal"},{"issue":"8","key":"10.1002\/14651858.CD006897.pub2-BIB2|cit2","first-page":"577","article-title":"\"[The effects and therapeutic duration of oral corticosteroids in patients with acute exacerbation of chronic obstructive pulmonary diseases]. [Chinese]\"","volume":"31","author":"Chen","year":"2008","journal-title":"Chinese Journal of Tuberculosis & Respiratory Diseases [Chung-Hua Chieh Ho Ho Hu Hsi Tsa Chih]"},{"key":"10.1002\/14651858.CD006897.pub2-BIB3|cit3","series-title":"European Respiratory Society Annual Congress, Berlin, Germany, October 4-8","first-page":"[P3601]","article-title":"Duration of systemic corticosteroids treatment in COPD exacerbations [Abstract]","author":"Gomaa","year":"2008"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD006897.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"839S","DOI":"10.1378\/chest.126.4_MeetingAbstracts.839S-a","article-title":"Role of 7-day and 14-day courses of oral prednisolone treatment in acute exacerbation of COPD [Abstract]","volume":"126","author":"Rahman","year":"2004","journal-title":"Chest"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD006897.pub2-BIB5|cit5","first-page":"A801","article-title":"Optimal duration of corticosteroid therapy in the treatment of exacerbations of chronic obstructive pulmonary disease","volume":"157","author":"Salam","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006897.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1378\/chest.119.3.726","article-title":"Systemic glucocorticoids in severe exacerbations of COPD","volume":"119","author":"Sayiner","year":"2001","journal-title":"Chest"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD006897.pub2-BIB7|cit7","first-page":"A120 [012-01]","article-title":"Comparison between 5 days and 10 days of prednisolone in treatment of acute exacerbation of chronic obstructive pulmonary disease [Abstract]","volume":"13","author":"Sirichana","year":"2008","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD006897.pub2-BIB8|cit8","first-page":"262","article-title":"A double-blind, randomised, placebo-controlled trial of corticosteroids for acute exacerbations of chronic obstructive pulmonary disease [Abstract]","volume":"28","author":"Wood-Baker","year":"1998","journal-title":"Australian & New Zealand Journal of Medicine"},{"issue":"26","key":"10.1002\/14651858.CD006897.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1056\/NEJMoa023161","article-title":"Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease [comment]","volume":"348","author":"Aaron","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD006897.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-92-6-753","article-title":"Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency","volume":"92","author":"Albert","year":"1980","journal-title":"Annals of Internal Medicine"},{"issue":"9629","key":"10.1002\/14651858.CD006897.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(08)60845-4","article-title":"A PEACE-ful solution to COPD exacerbations? [comment]","volume":"371","author":"Albert","year":"2008","journal-title":"Lancet"},{"issue":"Suppl.2","key":"10.1002\/14651858.CD006897.pub2-BIB12|cit12","first-page":"17","article-title":"Corticosteroid therapy for COPD exacerbations at inpatient settings: a controlled-randomized study","volume":"32","author":"Cordero","year":"1996","journal-title":"Archivos de Bronconeumologia"},{"key":"10.1002\/14651858.CD006897.pub2-BIB13|cit13","first-page":"110s","article-title":"A randomized controlled study of prednisone in outpatients with acute exacerbation of COPD","volume":"9 Suppl 23","author":"Cordero","year":"1996","journal-title":"European Respiratory Journal. Supplement"},{"issue":"10","key":"10.1002\/14651858.CD006897.pub2-BIB14|cit14","first-page":"762","article-title":"Oral prednisone prevents relapse in COPD exacerbations","volume":"52","author":"Courtney","year":"2003","journal-title":"Journal of Family Practice"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD006897.pub2-BIB15|cit15","first-page":"A5 S18","article-title":"A prospective, randomised, double-blind, placebo controlled study of oral corticosteroids in patients admitted with normocapnic acute exacerbations of chronic obstructive pulmonary disease (COPD)","volume":"52","author":"Davies","year":"1997","journal-title":"Thorax"},{"issue":"9177","key":"10.1002\/14651858.CD006897.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0140-6736(98)11326-0","article-title":"Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial","volume":"354","author":"Davies","year":"1999","journal-title":"Lancet"},{"issue":"Suppl 48","key":"10.1002\/14651858.CD006897.pub2-BIB17|cit17","first-page":"64s","article-title":"A comparison of intravenous versus oral administration of corticosteroids in the treatment of patients admitted to the hospital with an exacerbation of COPD [Abstract]","volume":"24","author":"Jong","year":"2004","journal-title":"European Respiratory Journal"},{"issue":"6","key":"10.1002\/14651858.CD006897.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1378\/chest.07-0208","article-title":"Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study.[see comment]. Comment in: Chest. 2007 Dec;132(6):1728-9; PMID: 18079214","volume":"132","author":"Jong","year":"2007","journal-title":"Chest"},{"key":"10.1002\/14651858.CD006897.pub2-BIB19|cit19","unstructured":"GlaxoSmithKline A single centre, randomised, double-blind, parallel group study to compare the efficacy of nebulised fluticasone propionate 2 mg twice daily (bd) with placebo in patients with moderate to severe chronic obstructive pulmonary disease GlaxoSmithKline Clinical Trial Register 2005"},{"issue":"2","key":"10.1002\/14651858.CD006897.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1440-1843.2003.00468.x","article-title":"A step-wise application of methylprednisolone versus dexamethasone in the treatment of acute exacerbations of COPD","volume":"8","author":"Li","year":"2003","journal-title":"Respirology"},{"issue":"Suppl 31","key":"10.1002\/14651858.CD006897.pub2-BIB21|cit21","first-page":"50s","article-title":"The application of methylprednisolone in acute exacerbations of COPD","volume":"16","author":"Li","year":"2000","journal-title":"European Respiratory Journal"},{"issue":"1","key":"10.1002\/14651858.CD006897.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0735-6757(00)90073-1","article-title":"The results of a randomized controlled trial of hydrocortisone in acute exacerbation of COPD","volume":"18","author":"McCrory","year":"2000","journal-title":"American Journal of Emergency Medicine"},{"key":"10.1002\/14651858.CD006897.pub2-BIB23|cit23","unstructured":"Reid D Soltani A Wood-Baker R Walters EH Personal correspondence 2010"},{"issue":"18 October 2010","key":"10.1002\/14651858.CD006897.pub2-BIB24|cit24","first-page":"w13109","article-title":"Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease - the \"REDUCE\" trial","volume":"140","author":"Schuetz","year":"2011","journal-title":"Swiss Medical Weekly"},{"issue":"2","key":"10.1002\/14651858.CD006897.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease","volume":"106","author":"Anthonisen","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006897.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/COPD.S1210","article-title":"Airways inflammation and treatment during acute exacerbations of COPD","volume":"3","author":"Bathoorn","year":"2008","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"3","key":"10.1002\/14651858.CD006897.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1378\/chest.06-1610","article-title":"Impact of COPD exacerbations on patient-centered outcomes","volume":"131","author":"Cote","year":"2007","journal-title":"Chest"},{"issue":"1","key":"10.1002\/14651858.CD006897.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/art.22294","article-title":"Fracture risk with intermittent high-dose oral glucocorticoid therapy","volume":"56","author":"Vries","year":"2007","journal-title":"Arthritis & Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD006897.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1164\/ajrccm.150.1.8025735","article-title":"Corticosteroids contribute to muscle weakness in chronic airflow obstruction","volume":"150","author":"Decramer","year":"1994","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD006897.pub2-BIB30|cit30","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184.ch9","article-title":"Chapter 9: Analysing data and undertaking meta-analyses","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]","author":"Deeks","year":"2008"},{"key":"10.1002\/14651858.CD006897.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD006897.pub2-BIB32|cit32","first-page":"670","article-title":"Chronic obstructive pulmonary disease: diagnostic considerations","volume":"73","author":"Dewar","journal-title":"American Family Physician"},{"key":"10.1002\/14651858.CD006897.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/thx.2005.041806","article-title":"COPD exacerbations 1: epidemiology","volume":"61","author":"Donaldson","year":"2006","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD006897.pub2-BIB34|cit34","unstructured":"GOLD Global Strategy for Diagnosis, Management and Prevention of COPD - Updated 2010 http:\/\/www.goldcopd.org\/guidelines-global-strategy-for-diagnosis-management.html"},{"key":"10.1002\/14651858.CD006897.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006897.pub2-BIB36|cit36","doi-asserted-by":"crossref","unstructured":"Higgins J Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September2008]. The Cochrane Collaboration, 2009 Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD006897.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/0470868678.ch2","article-title":"Chronic obstructive pulmonary disease: an overview of pathology and pathogenesis","volume":"234","author":"Hogg","year":"2001","journal-title":"Novartis Foundation Symposium"},{"issue":"2","key":"10.1002\/14651858.CD006897.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.rmed.2009.09.013","article-title":"Prevalence and predictors of vertebral fracture in patients with chronic obstructive pulmonary disease","volume":"104","author":"Majumdar Sumit","year":"2010","journal-title":"Respiratory Medicine"},{"issue":"Suppl","key":"10.1002\/14651858.CD006897.pub2-BIB39|cit39","first-page":"S7","article-title":"The COPDX Plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease 2003","volume":"178","author":"McKenzie","year":"2003","journal-title":"Medical Journal of Australia"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD006897.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1164\/ajrccm.152.4.7551388","article-title":"Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush","volume":"152","author":"Monso","year":"1995","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD006897.pub2-BIB41|cit41","volume-title":"The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020","author":"Murray","year":"1996"},{"key":"10.1002\/14651858.CD006897.pub2-BIB42|cit42","unstructured":"National Collaborating Centre for Chronic Conditions Chronic Obstructive Pulmonary Disease. National Clinical Guideline on Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care (update 2010) http:\/\/guidance.nice.org.uk\/CG101 (Accessed 18\/07\/11)"},{"key":"10.1002\/14651858.CD006897.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1164\/ajrccm.163.5.2101039","article-title":"Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease","volume":"163","author":"Pauwels","year":"2001","journal-title":"American Journal of Respiratory & Critical Care Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006897.pub2-BIB44|cit44","first-page":"262","article-title":"Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation","volume":"53","author":"Pela","year":"1998","journal-title":"Monaldi Archives of Chest Disease"},{"key":"10.1002\/14651858.CD006897.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00063198-200203000-00003","article-title":"Chronic obstructive pulmonary disease in the United Kingdom: trends in mortality, morbidity and smoking","volume":"8","author":"Pride","year":"2002","journal-title":"Current Opinion in Pulmonary Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006897.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1513\/pats.2306026","article-title":"Exacerbations and progression of disease in asthma and chronic obstructive pulmonary disease","volume":"1","author":"Rennard","year":"2004","journal-title":"Proceedings of the American Thoracic Society"},{"key":"10.1002\/14651858.CD006897.pub2-BIB47|cit47","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"issue":"5 Suppl 2","key":"10.1002\/14651858.CD006897.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"398S","DOI":"10.1378\/chest.117.5_suppl_2.398S","article-title":"Toward a consensus definition for COPD exacerbations","volume":"117","author":"Rodriguez-Roisin","year":"2000","journal-title":"Chest"},{"key":"10.1002\/14651858.CD006897.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","article-title":"Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease","volume":"157","author":"Seemungal","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"5","key":"10.1002\/14651858.CD006897.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1164\/ajrccm.161.5.9908022","article-title":"Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease","volume":"161","author":"Seemungal","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"7","key":"10.1002\/14651858.CD006897.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJMoa012561","article-title":"New strains of bacteria and exacerbations of chronic obstructive pulmonary disease","volume":"347","author":"Sethi","year":"2002","journal-title":"The New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD006897.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/thx.2006.064410","article-title":"Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample","volume":"61","author":"Shahab","year":"2006","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD006897.pub2-BIB53|cit53","volume-title":"Therapeutic Guidelines: Respiratory. Version 4","author":"Therapeutic Guidelines","year":"2009"},{"issue":"3","key":"10.1002\/14651858.CD006897.pub2-BIB54|cit54","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005374","article-title":"Oral corticosteroids for stable chronic obstructive pulmonary disease","author":"Walters","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006897.pub2-BIB55|cit55","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001288.pub2","article-title":"Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease","author":"Wood-Baker","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Supplement 3","key":"10.1002\/14651858.CD006897.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0954-6111(03)80020-3","article-title":"Economic analysis of the confronting COPD survey: an overview of results","volume":"97","author":"Wouters","year":"2003","journal-title":"Respiratory Medicine"}],"updated-by":[{"DOI":"10.1002\/14651858.cd006897.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T00:00:00Z","timestamp":1418169600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006897.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:04:55Z","timestamp":1628546695000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006897.pub2"}},"subtitle":[],"editor":[{"given":"Julia AE","family":"Walters","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,10,5]]},"references-count":56,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006897.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD006897.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2011,10,5]]}}}